Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Immunotherapy-based combinations: an update.

Fucà G, de Braud F, Di Nicola M.

Curr Opin Oncol. 2018 Jul 9. doi: 10.1097/CCO.0000000000000466. [Epub ahead of print]

PMID:
29994900
2.

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Morano F, Fuca G, Nikolinakos P, Drilon A, Hechtman JF, Christiansen J, Gowen K, Frampton GM, Gasparini P, Rossini D, Gigliotti C, Kim ST, Prisciandaro M, Hodgson J, Zaniboni A, Chiu VK, Milione M, Patel R, Miller V, Bardelli A, Novara L, Wang L, Pupa SM, Sozzi G, Ross J, Di Bartolomeo M, Bertotti A, Ali S, Trusolino L, Falcone A, de Braud F, Cremolini C.

Ann Oncol. 2018 Jun 1;29(6):1394-1401. doi: 10.1093/annonc/mdy090.

PMID:
29538669
3.

Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis.

Ratta R, Verzoni E, Di Maio M, Grassi P, Colecchia M, Fucà G, de Braud F, Procopio G.

Clin Genitourin Cancer. 2018 Feb 5. pii: S1558-7673(18)30075-2. doi: 10.1016/j.clgc.2018.01.016. [Epub ahead of print]

PMID:
29478961
4.

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Tejpar S, Sartore-Bianchi A, Hechtman JF, Christiansen J, Novara L, Tebbutt N, Fucà G, Antoniotti C, Kim ST, Murphy D, Berenato R, Morano F, Sun J, Min B, Stephens PJ, Chen M, Lazzari L, Miller VA, Shoemaker R, Amatu A, Milione M, Ross JS, Siena S, Bardelli A, Ali SM, Falcone A, de Braud F, Cremolini C.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx089.

PMID:
29370427
5.

Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study.

Cremolini C, Pietrantonio F, Tomasello G, Dadduzio V, Moretto R, Morano F, Schirripa M, Antoniotti C, Fucà G, Bergamo F, Rossini D, Nichetti F, Ziampiri S, Ghidini M, Marmorino F, Prisciandaro M, Falcone A, De Braud F, Loupakis F, Lonardi S.

ESMO Open. 2017 Aug 10;2(3):e000241. doi: 10.1136/esmoopen-2017-000241. eCollection 2017.

6.

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.

Pietrantonio F, Fucà G, Morano F, Gloghini A, Corso S, Aprile G, Perrone F, De Vita F, Tamborini E, Tomasello G, Gualeni AV, Ongaro E, Busico A, Giommoni E, Volpi CC, Laterza MM, Corallo S, Prisciandaro M, Antista M, Pellegrinelli A, Castagnoli L, Pupa SM, Pruneri G, de Braud F, Giordano S, Cremolini C, Di Bartolomeo M.

Clin Cancer Res. 2018 Mar 1;24(5):1082-1089. doi: 10.1158/1078-0432.CCR-17-2781. Epub 2017 Dec 5.

PMID:
29208673
7.

TARIBO Trial: Targeted Therapy with or without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery.

Verzoni E, Ratta R, Grassi P, Salvioni R, Stagni S, Montone R, Fucà G, Cappelletti V, Reduzzi C, De Giorgi U, Procopio G.

Tumori. 2017 Nov 1:tj5000699. doi: 10.5301/tj.5000699. [Epub ahead of print]

PMID:
29192741
8.

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.

Cremolini C, Morano F, Moretto R, Berenato R, Tamborini E, Perrone F, Rossini D, Gloghini A, Busico A, Zucchelli G, Baratelli C, Tamburini E, Tampellini M, Sensi E, Fucà G, Volpi C, Milione M, Di Maio M, Fontanini G, De Braud F, Falcone A, Pietrantonio F.

Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.

PMID:
29045518
9.

Multimodal treatment of advanced renal cancer in 2017.

Mennitto A, Verzoni E, Grassi P, Ratta R, Fucà G, Procopio G.

Expert Rev Clin Pharmacol. 2017 Dec;10(12):1395-1402. doi: 10.1080/17512433.2017.1386552. Epub 2017 Oct 6. Review.

PMID:
28956645
10.

Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient.

Milione M, Ardini E, Christiansen J, Valtorta E, Veronese S, Bosotti R, Pellegrinelli A, Testi A, Pietrantonio F, Fucà G, Wei G, Murphy D, Siena S, Isacchi A, De Braud F.

Oncotarget. 2017 Jul 24;8(33):55353-55360. doi: 10.18632/oncotarget.19512. eCollection 2017 Aug 15.

11.

Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.

Berenato R, Morano F, Pietrantonio F, Cotsoglou C, Caporale M, Infante G, Pellegrinelli A, Alessi A, Battiston C, Coppa J, Padovano B, Mennitto A, Niger M, Fucà G, Lazzati S, Greco G, Delconte G, de Braud F, Mazzaferro V, Di Bartolomeo M.

Oncology. 2017;93(5):279-286. doi: 10.1159/000479154. Epub 2017 Sep 8.

PMID:
28881354
12.

Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.

Maltese G, Fontanella C, Lepori S, Scaffa C, Fucà G, Bogani G, Provenzano S, Carcangiu ML, Raspagliesi F, Lorusso D.

Oncology. 2018;94(1):1-6. doi: 10.1159/000479818. Epub 2017 Sep 5.

PMID:
28869928
13.

Castration-naive metastatic prostate cancer: reshaping old paradigms.

Ratta R, Grassi P, Fucà G, Verzoni E, Procopio G.

Expert Rev Anticancer Ther. 2017 Oct;17(10):879-881. doi: 10.1080/14737140.2017.1374178. Epub 2017 Sep 11. No abstract available.

PMID:
28854837
14.

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.

Oddo D, Siravegna G, Gloghini A, Vernieri C, Mussolin B, Morano F, Crisafulli G, Berenato R, Corti G, Volpi CC, Buscarino M, Niger M, Dunne PD, Rospo G, Valtorta E, Bartolini A, Fucà G, Lamba S, Martinetti A, Di Bartolomeo M, de Braud F, Bardelli A, Pietrantonio F, Di Nicolantonio F.

Br J Cancer. 2017 Jul 25;117(3):347-352. doi: 10.1038/bjc.2017.196. Epub 2017 Jun 27.

PMID:
28654634
15.

Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block.

Sassone B, Bertini M, Beltrami M, Malagù M, Pasanisi G, Kuwornu HA, Avigni N, Fucà G, Pacchioni F, Minarelli M, Bacchi Reggiani ML, Padeletti L.

Am J Cardiol. 2017 Jun 1;119(11):1803-1808. doi: 10.1016/j.amjcard.2017.02.043. Epub 2017 Mar 16.

PMID:
28391991
16.

Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer.

Bogani G, Sabatucci I, Maltese G, Lecce F, Signorelli M, Martinelli F, Chiappa V, Indini A, Leone Roberti Maggiore U, Borghi C, Fucà G, Ditto A, Raspagliesi F, Lorusso D.

Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:41-45. doi: 10.1016/j.ejogrb.2016.11.017. Epub 2016 Nov 19.

PMID:
27888705
17.

Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.

Raspagliesi F, Maltese G, Bogani G, Fucà G, Lepori S, De Iaco P, Perrone M, Scambia G, Cormio G, Bogliolo S, Bergamini A, Bifulco G, Casali PG, Lorusso D.

Gynecol Oncol. 2017 Jan;144(1):90-95. doi: 10.1016/j.ygyno.2016.11.002. Epub 2016 Nov 4.

PMID:
27817933
18.

Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis.

Bogani G, Fucà G, Maltese G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Scaffa C, Sabatucci I, Lecce F, Raspagliesi F, Lorusso D.

Gynecol Oncol. 2016 Nov;143(2):443-447. doi: 10.1016/j.ygyno.2016.07.110. Epub 2016 Jul 29. Review.

PMID:
27481579
19.

Relation of QRS duration to response to cardiac resynchronization therapy.

Sassone B, Gambetti S, Bertini M, Beltrami M, Mascioli G, Bressan S, Fucà G, Pacchioni F, Pedaci M, Michelotti F, Bacchi Reggiani ML, Padeletti L.

Am J Cardiol. 2015 Jan 15;115(2):214-9. doi: 10.1016/j.amjcard.2014.10.024. Epub 2014 Oct 30.

PMID:
25465934
20.

[Focal acute myocarditis mimicking ST-elevation myocardial infarction: a case report and literature review].

Gambetti S, Fucà G, Bressan S, Righi R, Sassone B.

G Ital Cardiol (Rome). 2014 Nov;15(11):634-7. doi: 10.1714/1694.18510. Review. Italian.

PMID:
25424142
21.

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.

Valgimigli M, Campo G, Monti M, Vranckx P, Percoco G, Tumscitz C, Castriota F, Colombo F, Tebaldi M, Fucà G, Kubbajeh M, Cangiano E, Minarelli M, Scalone A, Cavazza C, Frangione A, Borghesi M, Marchesini J, Parrinello G, Ferrari R; Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators.

Circulation. 2012 Apr 24;125(16):2015-26. doi: 10.1161/CIRCULATIONAHA.111.071589. Epub 2012 Mar 21.

22.

Assessment of systolic ejection time as a hemodynamic marker of incipient bradycardic vasovagal syncope. A pilot study.

Fucà G, Dinelli M, Gianfranchi L, Bressan S, Corbucci G, Alboni P.

Pacing Clin Electrophysiol. 2011 Aug;34(8):954-62. doi: 10.1111/j.1540-8159.2011.03094.x. Epub 2011 Mar 31.

PMID:
21453342
23.

Do subjects with vasovagal syncope have subtle haemodynamic alterations during orthostatic stress?

Fucà G, Dinelli M, Gianfranchi L, Bressan S, Lamborghini C, Alboni P.

Europace. 2008 Jun;10(6):751-9. doi: 10.1093/europace/eun067. Epub 2008 Mar 29.

PMID:
18375967
24.

Oral necrotizing microvasculitis in a patient affected by Kawasaki disease.

Scardina GA, Fucà G, Carini F, Valenza V, Spicola M, Procaccianti P, Messina P, Maresi E.

Med Oral Patol Oral Cir Bucal. 2007 Dec 1;12(8):E560-4.

25.

Microvascular characteristics of the human interdental papilla.

Scardina GA, Fucà G, Messina P.

Anat Histol Embryol. 2007 Aug;36(4):266-8.

PMID:
17617103
26.

Oral diseases in a patient affected with Prader-Willi syndrome.

Scardina GA, Fucà G, Messina P.

Eur J Paediatr Dent. 2007 Jun;8(2):96-9.

PMID:
17571934
27.

The venous system is the main determinant of hypotension in patients with vasovagal syncope.

Fucà G, Dinelli M, Suzzani P, Scarfò S, Tassinari F, Alboni P.

Europace. 2006 Oct;8(10):839-45. Epub 2006 Aug 17.

PMID:
16916860
28.

Sexual activity with and without the use of sildenafil: risk of cardiovascular events in patients with heart disease.

Alboni P, Bettiol K, Fucà G, Pacchioni F, Scarfò S.

Ital Heart J. 2004 May;5(5):343-9. Review.

PMID:
15185897
29.

Is an individualized treatment possible in patients with paroxysmal supraventricular reentrant tachycardia?

Alboni P, Gianfranchi L, Fucà G.

Ital Heart J. 2002 Dec;3(12):738-42. No abstract available.

PMID:
12611126
30.

Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.

Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fucà G, Brignole M, Cappato R.

J Am Coll Cardiol. 2001 Feb;37(2):548-53.

31.

Development of heart failure in bradycardic sick sinus syndrome.

Alboni P, Scarfò S, Fucà G.

Ital Heart J. 2001 Jan;2(1):9-12. Review.

PMID:
11214707
32.

Atrioventricular nodal versus atrioventricular supraventricular reentrant tachycardias: characterization by an integrated Doppler electrophysiological hemodynamic study.

Mele D, Alboni P, Fucà G, Scarfò S, Paparella N, Levine RA.

Pacing Clin Electrophysiol. 2000 Dec;23(12):2078-85.

PMID:
11202251
33.

Echocardiographic prediction of clinical outcome in medically treated patients with aortic stenosis.

Rossi A, Tomaino M, Golia G, Anselmi M, Fucá G, Zardini P.

Am Heart J. 2000 Nov;140(5):766-71.

PMID:
11054623
34.

Significance of newly acquired negative T waves after interruption of paroxysmal reentrant supraventricular tachycardia with narrow QRS complex.

Paparella N, Ouyang F, Fucă G, Kuck KH, Cappato R, Alboni P.

Am J Cardiol. 2000 Jan 15;85(2):261-3.

PMID:
10955389
35.

[Arrhythmias and sexual activity].

Alboni P, Baggioni GF, Fucà G, Bettiol K, Donateo M.

G Ital Cardiol. 1999 Nov;29(11):1370-5; discussion 1376-7. Review. Italian. No abstract available.

PMID:
10609144
36.

Atrial and ventricular pressures in atrial flutter.

Alboni P, Scarfò S, Fucà G, Paparella N, Mele D.

Pacing Clin Electrophysiol. 1999 Apr;22(4 Pt 1):600-4.

PMID:
10234713
37.

Short-term hemodynamic effects of DDD pacing from ventricular apex, right ventricular outflow tract and proximal septum.

Alboni P, Scarfò S, Fucà G, Mele D, Dinelli M, Paparella N.

G Ital Cardiol. 1998 Mar;28(3):237-41.

PMID:
9561877
38.

Effects of intravenous propranolol on cardiovascular hemodynamics during supraventricular tachycardia.

Alboni P, Fucà G, Paparella N, Scarfò S, Pirani R.

Am J Cardiol. 1996 Aug 1;78(3):347-50.

PMID:
8759819
39.

Hemodynamics of idiopathic paroxysmal atrial fibrillation.

Alboni P, Scarfò S, Fucà G, Paparella N, Yannacopulu P.

Pacing Clin Electrophysiol. 1995 May;18(5 Pt 1):980-5.

PMID:
7659571
40.

Hemodynamic effects of oral propafenone during both sinus rhythm and atrial fibrillation.

Alboni P, Scarfò S, Fucà G, Paparella N, Pedini I, Mele D.

Am J Cardiol. 1995 Jan 1;75(1):91-3. No abstract available.

PMID:
7801877
41.

Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.

Alboni P, Razzolini R, Scarfò S, Paparella N, Fucà G, Pedini I, Chioin R.

J Am Coll Cardiol. 1993 Nov 1;22(5):1373-7.

42.

Reproductive performance in women with uterus didelphys.

Maneschi I, Maneschi F, Parlato M, Fucà G, Incandela S.

Acta Eur Fertil. 1989 May-Jun;20(3):121-4.

PMID:
2624066
43.

Reproductive impairment of women with unicornuate uterus.

Maneschi M, Maneschi F, Fucà G.

Acta Eur Fertil. 1988 Sep-Oct;19(5):273-5.

PMID:
3252657

Supplemental Content

Support Center